Product Reports Resources Pricing Login Book a demo

NEOGAP Therapeutics

Biotech & Life Sciences · Stockholm, Sweden · Founded 2016

Imagine if cancer patients who lack efficient treatment options could be cured MoreLess

Developer of personalized cancer immunotherapy designed to precisely target and eliminate cancer. The company's product identifies optimal neoantigens to target, activate and multiply T-lymphocytes with the purpose of eradicating cancer, enabling cancer patients to recover from the disease. Keywords: Pharmaceuticals and Biotechnology, Biopharmaceutical Producer, Biopharmaceutical Research, Cancer Cure Therapy, Immune System, Immuno-Oncology Drugs, Immunotherapy Drugs, Pharmaceutical, Pharmaceutical Medicine.

Talent graph

NEOGAP Therapeutics's talent

Book a demo to see the people
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

2 investors on NEOGAP Therapeutics's cap table

Sourced from Dealroom's funding and investor records.

Seed 1 investor entered at this stage
European Innovation Council
Series A 1 investor entered at this stage
Sciety

Global footprint

Where NEOGAP Therapeutics has talent and traffic

Workforce by country
1 countries with
team presence
🇸🇪 Sweden100%
1 country shown

Market sentiment

What the market is saying about NEOGAP Therapeutics

An AI-synthesized read of the highest-engagement posts about NEOGAP Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See NEOGAP Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.